Petrasek et al. found that in vivo disruption with anakinra, a recombinant IL-1 receptor (IL-1Rα), inhibited IL-1 signaling and significantly ameliorated ethanol-induced hepatic inflammation, hepatic injury, and steatosis (42). This evidence concerns the gene IL1B and steatosis.